Dong et al., further demonstrated that AGR2 in esophageal adenocarcinoma promotes tumor growth by inducing AGR2 expression of and regulates the Hippo signaling pathway co-activator [53]. Here, AGR2 is linked to esophageal adenocarcinoma.